StockTipsArenaBeta

BUY Emcure Pharmaceuticals Limited — Akshay Bhagwat, JM Financial

BUYEmcure Pharmaceuticals Limited

byAkshay Bhagwat, JM FinancialHorizon: 1–3 months8 Apr 2026via Business Today

Entry₹1,572Inferred
Target₹1,750
Total upside +11.32% (call closed)
Stop loss₹1,500-4.58% risk
Exit₹1,50021 Apr 2026, 12:00 am
Stop-loss hit-4.58%
Follow Akshay Bhagwat for new calls(50% target hit, 34 closed calls)Get alertsWatch EMCURE for new buy/sell callsGet alertsSee 1 active Short-term call on EMCURESee 10 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 5:43 pm IST
2 supporting0 opposing
Supports the BUY call (2)

1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·15 Apr · 5d ago

1 advisor has an active long-term BUY call on this stock

Advisor consensus · adjacent horizon·5 Feb · 2mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.